Document is current
Any future updates will be listed below
-
Authors
García, Luis Fernando
Conde, Esther
Hernandez, Susana
Alonso, Marta
Curto, Daniel
Dómine, Manuel
Rojo, Federico
Freire, Javier
Gómez-Román, Javier
Calles, Antonio
Cebollero, María
González-Larriba, José Luis
Saiz, Melchor
Esteban, Isabel
Gutiérrez, Laura
Lopez-Rios, Fernando https://orcid.org/0000-0001-6813-0395
de Castro, Javier
-
Funding
Funding for this research was provided by:
Fundación Mutua Madrileña (AP18051-2022)
Instituto de Salud Carlos III (PI22-01700)
Instituto de Salud Carlos III (DTS22/00145)
Comunidad de Madrid iLUNG Program (P2022/BMD-7437)
- License Information
-
More Information
Article History
Received: 8 May 2025
Accepted: 17 July 2025
First Online: 11 August 2025
Declarations
:
: Regarding the scope of this work, SH, FLR and EC have received funding and honoraria from Pfizer and Roche. MA has served as a speaker for Roche. JG-R has served as a speaker for Pfizer and Roche. The rest of the authors declare no conflicts of interest.
: The Institutional ethics committee “Hospital Universitario La Paz Madrid” reviewed and approved this study (number: 4654).
